1. Purdue joining pharma’s top settlement list alongside Merck, GSK, and Pfizer — Biosimilars running into more roadblocks in the US — Big Pharma companies pay for exclusive access to UK genetic data — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

2012 The Year of Great News !!

Discussion in 'Allos Therapeutics' started by Anonymous, Dec 22, 2011 at 10:09 AM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Next year is gonna be the best yet - I can hardly wait to get started. Happy Holidays and New Years to everyone in the Allos family. We will prosper !!
     
  2. Anonymous

    Anonymous Guest

    We will prosper if we leave. Otherwise we are dead.
     
  3. Anonymous

    Anonymous Guest

    Yes, "Live long and prosper" Spock! Find that movie under fiction or fantasy.
     
  4. Anonymous

    Anonymous Guest

    are you kidding me, great year wake up you idoit, not close even close next yr or ever! As long as we have Bern's leading we are toast! I can beleive our smart money investors allow PB to walk through the door after all the damage he has done and now did you read the last corporate filling regarding B goldfinger's salary, WOW !! We all know who's ass he has his head up!! the ship is sinking, no hope, its over!!
     
  5. Anonymous

    Anonymous Guest

    Wow, can you tell me where you bought those rose colored glasses you are obviously wearing?? Or better yet, what you are smoking? I want some of both!
     
  6. Anonymous

    Anonymous Guest

    January is feeling good !! Feb will be even better - love watching those sales rise !!!!!!
     
  7. Anonymous

    Anonymous Guest

    What is the current list price for the 20s and 40s?
     
  8. Anonymous

    Anonymous Guest

    MORE. . . . But so will QUOTAS
     
  9. Anonymous

    Anonymous Guest

    CHMP says NO!! Another nail in the coffin. Not that it needed any more nails
     
  10. Anonymous

    Anonymous Guest

    The coffin is already in the ground. There throwing dirt on us now.When the investment community realizes what a fuck up Paul Berns is- we will be below $1 per share. Mundi now has the opportunity to pull out just as Berns father should have....

    What a collasal fcuk wad
     
  11. Anonymous

    Anonymous Guest

    Year of Great News??? Here is your Weekend Update. The Pharma world that you knew is dead!! Want the actual numbers look here:

    http://www.biojobblog.com/2011/04/a...te-almost-300000-pharma-jobs-lost-since-2000/

    You are a blacksmith making horseshoes at the time the Model T is being introduced, but you are so invested you can't see what is happening. The bigger question for you isn't if and certainly when your little insignificant company goes away, but what happens to you after that. If you are over 40, you will need to find another career and many of you are, just look around at what has happened to others. Suggestion: Get your head out of your ass and move on.
     
  12. Anonymous

    Anonymous Guest

    Allos and Endocyte should merge creating a world leader in Folate medicines.
     
  13. Anonymous

    Anonymous Guest

    We tried. Endocyte said get the heck out they dont want to leave Indiana and Berns insisted on retaining his salary, back dated options, and title. Ron Ellis not buying the folotyn story and most importantly Ellis has only been given around 75000 shares, unlike our leader who has been given around 900,000 shares so financially its a bad deal for paul so we wont do it.
     
  14. Anonymous

    Anonymous Guest

    Thanks for the update.
     
  15. Anonymous

    Anonymous Guest

    What do you mean Ellis does not buy the Folotyn story?
     
  16. Anonymous

    Anonymous Guest

    He knows that its fools gold. Pralatrexate is an $80K mtx. Acitivity iis not efficacy and as a result a not a reason to prescibe PDX. Ron Ellis understands this, Berns and Schick do not.
     
  17. Anonymous

    Anonymous Guest

    Which is why we still sit unsold and $1.70 per share. Berns and his team should be fired.
     
  18. Anonymous

    Anonymous Guest

    Tim Smith. Tim Smith. Tim Smith.
     
  19. Anonymous

    Anonymous Guest

    I heard 18 million in quarterly sales any truth? Or more of the same, price increases disguised as growth?
     
  20. Anonymous

    Anonymous Guest

    What or who is the right company to merge with.